Skip to main content
. 2022 Jan 15;35(1):87–104. doi: 10.1007/s10334-021-00994-1

Fig. 3.

Fig. 3

Representative T2w images (A), DGE map after d-glucose i.v. injection (B), CEST contrast (C) and tumor pH maps (D) after iopamidol I.v. injection, fused 18F-FDG-PET/CT images (E) for 4T1 and PC3 tumor-bearing mice. Average values calculated for each tumor model of Glucose ΔST% (F), 18F-FDG PET uptake as %ID/cc (G) and tumor pH (H)